Skip to content
★ Sign in to follow
JS

Jacob Safier

Orgenesis Inc.Seracare Life Sciences Inc
Total declarations
37
Companies
2
▲ Purchases (33 ops.)
€218k
▼ Sales (3 ops.)
€15k

Latest filing published 04 Dec 2024 for Orgenesis Inc., €4,835.

Filing timeline

BuySale
Jacob Safier

Insider track record

Disclosed buys
33
Disclosed sells
3
Signal history

Closed purchases

Market purchases
33
Positive at T+90
100%
Median T+90
+17.9%

Based on 30 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 14 Feb 2024 · 998 days ago · €1,592
    -67.9%
    Entry US$4.80 · Close at T+365 US$1.54

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jacob Safier: trading record in brief

Jacob Safier discloses dealings in 2 companies, chiefly Orgenesis Inc. and Seracare Life Sciences Inc. Over a trading history stretching from 17 May 2007 to 24 June 2024, the count stands at 37 filings.

In open-market terms, that means 33 purchases worth €218k on one side and 3 sales worth €15k on the other. On balance, insiders were net buyers of €203k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. So far in 2024, the count stands at 33 purchases and 3 sales.

Half of the purchases are above €3,375 and half below. Across 30 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 30 purchases show a median change of +17.9%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.

The record was last updated on 4 December 2024 with an open-market purchase (€5,404) in Orgenesis Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jacob Safier

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    5,135 USD0SEC
    10,000 shares@ US$0.51352.1% of flowCommon StockSEC:0000921895-24-002878:2
    Canonical exit: 15 Jul 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    5,800 USD0SEC
    10,000 shares@ US$0.582.3% of flowCommon StockSEC:0000921895-24-002878:4
    Canonical exit: 22 Sept 2024 (T+90)
  • ▼
    10% OwnerExecutivesOrgenesis Inc.
    5,444 USD11SEC
    10,000 shares@ US$0.54442.2% of flowCommon StockSEC:0000921895-24-002878:1
  • ▼
    10% OwnerExecutivesOrgenesis Inc.
    5,001 USD11SEC
    10,000 shares@ US$0.50012.0% of flowCommon StockSEC:0000921895-24-002878:3
  • ▼
    10% OwnerExecutivesOrgenesis Inc.
    5,814 USD11SEC
    10,000 shares@ US$0.58142.3% of flowCommon StockSEC:0000921895-24-002878:5
  • ▲
    ExecutivesOrgenesis Inc.
    5,948 USD0SEC
    10,000 shares@ US$0.594847.1% of flowCommon StockSEC:0000921895-24-002878:0
    Canonical exit: 9 Jul 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    68,950 USD10SEC
    100,000 shares@ US$0.689527.7% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:1
    Canonical exit: 20 Dec 2023 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    16,780 USD10SEC
    25,000 shares@ US$0.67126.8% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:2
    Canonical exit: 27 Dec 2023 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    8,030 USD11SEC
    10,000 shares@ US$0.8033.3% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:3
    Canonical exit: 3 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    4,731 USD11SEC
    5,100 shares@ US$0.92761.9% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:4
    Canonical exit: 4 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    519 USD11SEC
    603 shares@ US$0.86080.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:5
    Canonical exit: 8 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    8,999 USD11SEC
    10,000 shares@ US$0.89993.6% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:6
    Canonical exit: 22 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    438 USD11SEC
    500 shares@ US$0.87520.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:7
    Canonical exit: 23 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    465 USD11SEC
    500 shares@ US$0.93050.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:8
    Canonical exit: 25 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    3,691 USD11SEC
    5,000 shares@ US$0.73811.5% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:9
    Canonical exit: 29 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    2,769 USD11SEC
    3,437 shares@ US$0.80561.1% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:10
    Canonical exit: 30 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    16,888 USD12SEC
    20,000 shares@ US$0.84446.8% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:11
    Canonical exit: 31 Jan 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    14,188 USD12SEC
    20,000 shares@ US$0.70945.7% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:12
    Canonical exit: 6 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    13,054 USD12SEC
    20,000 shares@ US$0.65275.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:13
    Canonical exit: 7 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    688 USD11SEC
    1,184 shares@ US$0.58080.3% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:14
    Canonical exit: 8 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    2,959 USD11SEC
    5,800 shares@ US$0.51011.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:15
    Canonical exit: 19 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    2,701 USD11SEC
    5,000 shares@ US$0.54021.1% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:16
    Canonical exit: 22 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    467 USD11SEC
    1,016 shares@ US$0.45950.2% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:17
    Canonical exit: 29 Feb 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    1,062 USD11SEC
    2,000 shares@ US$0.53090.4% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:18
    Canonical exit: 10 Mar 2024 (T+90)
  • ▲
    10% OwnerExecutivesOrgenesis Inc.
    1,626 USD11SEC
    3,000 shares@ US$0.54210.6% of flowCommon Stock (par value $0.01)SEC:0001193805-24-000230:19
    Canonical exit: 11 Mar 2024 (T+90)

25 of 37 declarations